Omnicare Pays $4.2M To End FCA Suit Over Amgen Kickbacks
Omnicare Inc. will pay $4.2 million to settle a whistleblower's False Claims Act suit alleging it solicited and received kickbacks to promote Amgen Inc.'s Aranesp anemia drug among Medicaid patients, the...To view the full article, register now.
Already a subscriber? Click here to view full article